Why Aveanna Healthcare Holdings Inc.’s (AVAH) Stock Is Up 5.27%
As of Friday, August 14, Aveanna Healthcare Holdings Inc.’s AVAH share price has surged by 5.27%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Stock Evaluator: Aveanna Healthcare Holdings Inc. (AVAH)
Aveanna Healthcare Holdings Inc. AVAH
$13.16
0.19
1.46%
August 21, 2026 4:00:00 PM
EST
Volume: 8,415,323
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Commentary & Analysis
Why Aveanna Healthcare Holdings Inc.’s (AVAH) Stock Is Up 14.81%
As of Thursday, August 13, Aveanna Healthcare Holdings Inc.’s AVAH share price has surged by 14.81%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
What You Need to Know About Aveanna Healthcare Holdings Inc.'s Q3 Earnings
Aveanna Healthcare Holdings Inc.'s fiscal Q3 earnings report was released on Thursday, August 13. Let's dive in to see if (AVAH) missed or beat analyst's expectations.Jenna Brashear
Why Aveanna Healthcare Holdings Inc.’s (AVAH) Stock Is Up 18.34%
As of Thursday, August 13, Aveanna Healthcare Holdings Inc.’s AVAH share price has surged by 18.34%, which has investors questioning if this is right time to sell.Omar Beirat
Is Aveanna Healthcare Holdings Inc. (AVAH) Overvalued?
We dive into why Aveanna Healthcare Holdings Inc. (AVAH) could be considered overvalued on 2026-08-05, based on AAII’s Value Score and Grade.Michael Rose
Financial Summary
| Share Statistics | AVAH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,871.8 | $1,968.0 | 58% |
|
| Shares Out (Mil) | 224.9 | 77.7 | 78% |
|
| Institutional Ownership | 91.8% | 86.6% | 60% |
|
| Float (Mil) | 89.4 | 52.1 | 59% |
|
| Beta | 1.93 | 0.75 | 92% |
|
| Avg Daily Volume (000s) | 4,879 | 612 | 92% |
|
| Price Change (52-week) |
82.8% | 79.8% | 88% |
|
| Growth | AVAH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 10.2% | 10.9% | 59% |
|
| Net Income (5yr) | 42.8% | (1.6%) | 92% |
|
| EPS (5yr) | 35.6% | 0.3% | 86 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (10.7%) | (17.9%) | 58% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 7 | 7 | 10 | |
| Current EPS | $0.203 | $0.821 | $0.865 | |
| Month Ago EPS | $0.173 | $0.707 | $0.776 | |
| # Rev Up | 1 | 3 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $0.164 | $0.683 | $0.746 | |
| Year/Year Chg | 12.8% | (21.8%) | (5.3%) | |
| Financials | AVAH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,603 | $1,504 | 64% |
|
| Net Income (TTM) (Mil) | $275 | $28 | 71% |
|
| EPS (TTM) | $1.292 | $0.200 | 64% |
|
| Operating Cash Flow (TTM) (Mil) | $168 | $162 | 57% |
|
| Net Cash Flow (TTM) (Mil) | ($4) | $9 | 35% |
|
| Long-Term Debt (Q1) (Mil) | $1,311 | $338 | 69% |
|
| Enterprise Value (Q1) (Mil) | $4,085 | $2,416 | 59% |
|
| Valuation | AVAH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 9.97 | 2.82 | 90% |
|
| P/E | 10.7 | 26.0 | 19% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.3 | 1.1 | 13% |
|
| Ratios | AVAH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 32.0% | 27.8% | 38% |
|
| Net Margin | 10.6% | 1.2% | 64% |
|
| ROA | 14.2% | 2.2% | 93% |
|
| ROE | 198.6% | 7.2% | 98% |
|
| Liabilities to Assets | 86.3% | 58.6% | 80% |
|
| F-Score | 6 | 5 | na |
|
Passing Stock Screens
As of 8/21/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Est Rev: Top 30 Up
Factors: Earnings Estimates
Introduction to the use of earnings estimates.
| Performance Since Inception: | 21.5% |
| +/- S&P 500: | +14.0 |
FACTOR STRATEGY
Est Rev: Up 5% Screen
Factors: Earnings Estimates
Introduction to the use of earnings estimates.
| Performance Since Inception: | 22.7% |
| +/- S&P 500: | +15.2 |
GURU STRATEGY
Kirkpatrick Bargain Screen
Factors: Value, Momentum
Investing model outlined in Charles Kirkpatrick's book, Beat the Market: Invest by Knowing What Stocks to Buy and What Stocks to Sell.
| Performance Since Inception: | 6.8% |
| +/- S&P 500: | -0.7 |
GURU STRATEGY
Lakonishok Screen
Factors: Value, Momentum
Identifying stocks trading at a discount to their industry norms but showing recent price strength and upward earnings revisions.
| Performance Since Inception: | 13.2% |
| +/- S&P 500: | +5.7 |
